This study is now complete
Stillbirth is very closely related to problems in the placenta. However, we don't fully understand how these problems happen, and what effects they have. Often, when a baby is stillborn, there is inflammation in the placenta. This is called villitis (a type of inflammation) of unknown etiology (cause), or VUE for short. Other studies have not found a cause for this inflammation such as a bacterium or virus.
We are interested in how this inflammation relates to problems in the placenta. To study this, we looked closely at how inflammation changes the placenta and if it changes how well the placenta works. Using a 'biobank' - a collection of biological samples - we looked at placental samples from pregnancies where the baby was stillborn. Our early work has shown that the number of white blood cells, which indicate inflammation, is increased in placental tissue in cases where there were reduced fetal movements. This was especially the case in pregnancies where the baby was then stillborn.
Tommy's researchers carried out a review of earlier studies which showed that inflammation, specifically VUE, was present in 15% of apparently normal pregnancies. They also confirmed that it was about twice as common in babies that experienced growth restriction. However, there have not been studies of enough patients to definitely associate it with stillbirth - we believe that this is worth researching further.
We studied which types of cell were present in areas of VUE in the placentas of women who had had a stillbirth. We found that the microscopic lesions in areas of VUE are made up of specific types white blood cells. We also observed, for the first time, evidence that cells involved in the body's immune response - T cells - were present in areas of placenta that looked otherwise healthy. The location and amount of the chemical messengers that these cells make was also altered in stillbirth with VUE.
Scientists carried out an experiment that allowed us to grow fragments of placenta with T cells that had been taken from mothers’ blood samples. Culturing the placenta samples and T cells together for 4 days changed the function of the placenta: it made less of an important hormone called hCG and more signals that are associated with inflammation. Culturing tissue with these inflammatory signals also caused a decrease in hCG.
Our work has shown that the cells and signals involved in VUE can damage how well the placenta works. The new experiments can be used as a basis for further studies into the effect of inflammation in the placenta, and how it is linked to stillbirth.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.
This study was fully funded by Tommy's and took place in a Tommy's centreHide details
More research projects
A recently published article, co-authored by Professor Catherine Williamson from Tommy’s Research Centre at King’s College London, suggests that certain pregnancy complications can indicate future health issues for women.
Tommy’s has received a grant from the UK Government’s Department for Health and Social Care to support the costs of its PregnancyHub information and support services throughout the summer, due to rising demand in the wake of coronavirus.
Although recruitment to some clinical trials had to be paused when coronavirus hit the UK, scientists at Tommy’s Research Centres across the UK are still hard at work, supporting women and families in our specialist clinics and sharing their latest studies with academic journals.
The day before Mother’s Day, and two days before the UK officially went into coronavirus lockdown, Zara Dawson found out she was having a miscarriage. Her third consecutive miscarriage in less than a year, and fourth consecutive loss, after losing her second son Jesse in 2018 to termination for medical reasons.